Gosset Ownership
Private
Employees
~4
Therapeutic Areas
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Babylon Biosciences General Information
Babylon Biosciences is a San Francisco-based biotech company developing small-molecule therapeutics for diseases of the brain. Their approach focuses on rescuing essential neural functions using a proprietary high-throughput screening platform. The company is in early stages and has not yet reported clinical results or advanced programs to human trials as of early 2025.[1][2][3]
Contact Information
Website
Primary Industry
Biotech
Corporate Office
San Francisco, California
United States
United States
Drug Pipeline
No pipeline data available
Key Partnerships
Mission BioCapital Platinum Program participant—received pre-seed funding and support services from Mission BioCapital and sponsors such as Alloy Therapeutics.[3]
Babylon Biosciences Funding
No funding data available
To view Babylon Biosciences's complete valuation and funding history, request access »